W
Wonderbelly
On a mission to revolutionize digestive health, especially for the 25% of Americans who suffer from consistent heartburn condition fastest-growing among 20 to 39 year-olds
About Wonderbelly
Wonderbelly is a health-focused startup that specializes in the production and sale of antacid medicine. The company's primary product, Wonderbelly Antacid™, is designed to combat common digestive issues such as heartburn, acid indigestion, and sour stomach. The product is unique in the market due to its use of Clean Label Project Certified Ingredients, which are vegan, non-GMO, and free from harmful additives like talc, dyes, parabens, artificial sweeteners, titanium dioxide, and genetically modified ingredients.
Read full description
The company operates in the healthcare and wellness market, specifically targeting consumers who are conscious about the ingredients in their medicine and prefer natural, clean alternatives. Wonderbelly's business model is based on the direct sale of its antacid product to consumers, likely through both online and physical retail channels.
The company's commitment to quality and safety is evident in its team of industry-leading medical advisors, which includes a former president of the American Gastroenterological Association, a pioneering gastroenterologist and neuroscientist, and one of America's top OB-GYNs. This strong medical backing adds credibility to the company's products and helps to instill trust in potential customers.
In summary, Wonderbelly is a promising startup in the health and wellness sector, offering a unique, clean-label antacid product backed by a team of medical experts. Its commitment to quality and safety, combined with a growing market of health-conscious consumers, positions it well for future growth.
At a glance
- Status
- Acquired
- Founded
- 2021
- Headquarters
- Austin, United States
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 60.1/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning Wonderbelly.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2026 | $0 | — | Procter & Gamble | ↗ |
| SERIES A✓Equity / VC | Apr 2024 | $12M | $48M | Silas Capital · L Catterton · Elizabeth Street Ventures · BrandProject | ↗ |
Growth signals
Latest recorded traffic for Wonderbelly is 7.1K monthly website visits, down 28.3% over the last three months. Wonderbelly's team declined 60% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
BrandProject
Elizabeth Street Ventures
Slow Ventures
The Venture Collective
Series A5 investors entered at this stage
Loft Growth Partners
Silas Capital
L Catterton
Jeremy Liew
AF Ventures
Other known investors1 additional known investor
Procter & Gamble
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Wonderbelly on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Wonderbelly’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.